Health AI Central
Share:
Peer-Reviewed Publication
Int J Chron Obstruct Pulmon Dis2026;21597524.January 1, 2026Journal Article

Response to the Letter to the Editor by Zambelli et al for In Silico Lung Deposition Profiles of Three Single-Inhaler Triple Therapies in Patients With COPD Using Functional Respiratory Imaging [Response To Letter].

Dave Singh1, Nicolas Roche2,3, Libo Wu4, Hosein Sadafi5, Jan De Backer6,7, Navid Monshi Tousi5, Jonathan Marshall8
1Respiratory Research Group, University of Manchester, Medicines Evaluation Unit, Manchester University National Health Service Foundation Trust, Manchester, UK.
2Department of Respiratory Medicine, Hospital Cochin, APHP Centre, Paris, France.
3Université Paris Cité, Institut Cochin, U1016, Paris, France.
4Product Development Operations, AstraZeneca, Durham, NC, USA.
5Department of Computational Engineering, FLUIDDA NV, Kontich, Belgium.
6FLUIDDA NV, Kontich, Belgium.
7Department of Respiratory Medicine, University of Antwerp, Antwerp, Belgium.
8Global Medical Respiratory, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.
PubMed PMC DOI PDF

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.